Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check32 days agoChange DetectedThe web page has added new sections on Immunologic Factors, Physiological Effects of Drugs, and Antibodies, Monoclonal, enhancing its core content significantly.SummaryDifference0.3%
- Check39 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new study on Metastatic Colorectal Cancer (mCRC) and the revision of the study version to v2.15.0. Key collaborators have been specified, and some previous content has been removed, indicating a shift in focus or details regarding the clinical study.SummaryDifference51%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check75 days agoChange DetectedThe page has been updated to include new sections on Immunologic Factors, Physiological Effects of Drugs, and Antibodies, Monoclonal.SummaryDifference0.3%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.